Amphastar P (AMPH) - Stock Price & Dividends

Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company that operates in the United States, China, and France. They focus on developing, manufacturing, marketing, and selling a variety of injectable, inhalation, and intranasal products.

The company operates through two main segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). They offer a range of products that cater to different medical needs, such as Primatene Mist for mild symptoms of intermittent asthma, Enoxaparin for deep vein thrombosis, Naloxone for opioid overdose, and more.

Amphastar also provides products like Lidocaine jelly for anesthetic purposes, Phytonadione injection for newborn babies, and Neostigmine methylsulfate injection for myasthenia gravis treatment. Their diverse product offerings include emergency syringes, morphine injection, Lorazepam injection, and many others.

Additionally, the company distributes recombinant human insulin APIs and porcine insulin API to various healthcare settings such as hospitals, care facilities, clinics, and doctors' offices. Established in 1996, Amphastar Pharmaceuticals, Inc. has its headquarters in Rancho Cucamonga, California.

For more information, visit their website at https://www.amphastar.com.